InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-25.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by CLARKE JOHN K, Director. Director active across 2 companies, notably aTYR PHARMA INC. Aggregated, 3 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €18k. History available since 21 May 2021. The latest transaction was disclosed on 21 May 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
6,000 sharesCommon StockSEC:0001209191-23-026069:0
2,500 shares@ US$4.340.012% mcap100.0% of flowCommon StockSEC:0001209191-21-035836:0
2,500 shares@ US$4.34100.0% of flowCommon StockSEC:0001209191-21-035836
3 of 3 declarations
About CLARKE JOHN K
John K. Clarke is a Board Member at aTYR PHARMA INC. He plays a crucial role in the strategic direction of the company, which focuses on developing treatments for rare diseases. His expertise helps guide key decisions for the company's future.
